BE693865A - - Google Patents

Info

Publication number
BE693865A
BE693865A BE693865DA BE693865A BE 693865 A BE693865 A BE 693865A BE 693865D A BE693865D A BE 693865DA BE 693865 A BE693865 A BE 693865A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE693865A publication Critical patent/BE693865A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
BE693865D 1966-02-10 1967-02-09 BE693865A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP738966 1966-02-10

Publications (1)

Publication Number Publication Date
BE693865A true BE693865A (ja) 1967-07-17

Family

ID=11664555

Family Applications (1)

Application Number Title Priority Date Filing Date
BE693865D BE693865A (ja) 1966-02-10 1967-02-09

Country Status (4)

Country Link
BE (1) BE693865A (ja)
DE (1) DE1618577B2 (ja)
FR (1) FR1510731A (ja)
GB (1) GB1125675A (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521429B1 (fr) * 1982-02-15 1988-10-28 Mayoly Spindler Laboratoires Nouvelles compositions a effet antiasthenique puissant a base de sels doubles de l'acide ascorbique et d'un diacide amine
HU194734B (en) * 1985-07-11 1988-03-28 Jozsef Bara Process for production of medical and applicable for human consumption products suitable for treatment and/or prevention of diseases caused by free-radical reactions
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
ATE444760T1 (de) * 1997-01-13 2009-10-15 Univ Emory Glutathion zur behandlung von influenzainfektionen
CN100346782C (zh) * 2004-05-21 2007-11-07 北京京卫信康医药科技发展有限公司 一种含氨基酸的维生素c组合物

Also Published As

Publication number Publication date
DE1618577B2 (de) 1973-02-08
DE1618577C3 (ja) 1973-09-13
GB1125675A (en) 1968-08-28
DE1618577A1 (de) 1972-02-24
FR1510731A (fr) 1968-01-19

Similar Documents

Publication Publication Date Title
AT281852B (ja)
AU5917865A (ja)
AU428063B2 (ja)
AU424443B2 (ja)
FR6859M (ja)
AU414526B2 (ja)
AU433222B2 (ja)
AU421822B2 (ja)
AU417216B2 (ja)
AU415165B1 (ja)
AU5895065A (ja)
AU1111066A (ja)
AU6703465A (ja)
AU612166A (ja)
AU1144366A (ja)
AU218666A (ja)
BE475118A (ja)
BE624001A (ja)
AU2390066A (ja)
AU407778B2 (ja)
BE692229A (ja)
AU411645B2 (ja)
AU6852465A (ja)
AU855865A (ja)
AU92366A (ja)